3 excellent ASX listed dividend shares from healthcare - HLS, SHL, ANN

Highlights PharmAust Limited updated the market about the testing of treatment for B Cell Lymphoma in pet dogs. Successful results are observed after the competition of phase 2 trial. It is expected that after the completion of phase 3, the MP...

Highlights Alcidion’s Miya Precision will support virtual care of acute diverticulitis patients via rpavirtual.  Key reference site highlighting the functionality of Miya Precision to be used in virtual care monitoring across hospita...

Highlights Healthcare sector is one of the world’s largest sectors serving every sphere with its products and services. Neuren Pharma has secured new US patent for NNZ-2591 in autism, valid till 2034. ResApp Health has submitted its obst...

Highlights  Neuren will start Phase two trials of its second drug candidate, NNZ-2591, for Angelman syndrome, Pitt Hopkins syndrome, Phelan-McDermid syndrome, and Prader-Willi syndrome.  Considering the urgent unmet need, all six...

Highlights Starpharma Holdings has signed a sales and distribution agreement for VIRALEZE™ with ADMENTA. Italian customers can get VIRALEZE™ in stores through LloydsFarmacia’s online platform this quarter. The OTC pharmaceuti...

The global biotech industry has been on investors’ radar, with the COVID-19 pandemic highlighting the necessity of identifying new drug development models and finding solutions for neglected diseases. As a result, the year 2021 saw a signific...

Highlights ECS Botanics share price has moved up on ASX. ASX:ECS has hit a record quarterly revenue number. Here’s why its upward trajectory is to continue in FY-22. Industrial Hemp and medicinal cannabis company ECS Botanics Holdin...

Highlights Wesfarmers has acquired a 19.3% stake in Australian Pharmaceutical Industries after moving forward on its agreement with Washington H. Soul Pattinson. Wesfarmers is confident that its proposal would offer an appealing premium and som...

Highlights The one-third of milk produced in Australia is processed to high-quality formulations and supplied to key global markets. In 2021, the total milk production in Australia is set to increase by 2% to 9 billion litres. Australian Dairy...

Highlights The high-intensity R&D activities in the healthcare industry always present excellent opportunities for long-term investment. Healius, Sonic Healthcare, Cochlear, CSL Limited and ResMed are few prominent ASX-listed healthcare com...